The National Cancer Center has developed an artificial intelligence system to predict the efficacy of new drugs. Other recent developments in cancer research and treatment include the creation of machine learning models to analyze liquid biopsy samples and updates to cancer screening guidelines. It is unclear how these advancements are related to each other or to other reported developments in cancer care and research.